Company / Return on Assets (ROA)
NOVAVAX INC Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
37.4%
FY2025
5-year range
-67.7% / 37.4%
FY2021-FY2025
Trend
+411.3%
vs FY2024
Sector context
#5 of 213
Health Care
What the data says
Return on Assets (ROA) changed +411% YoY in FY2025, a notable deviation from the 9-year average annual change of +13%.
Based on SEC 10-K filings.
37.4% in FY2025 with a 5-year CAGR of +63.8%. Top quartile in the Health Care sector.
Improved from -30.3% to 37.4% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +55.9pp
- 5-Year Change
- +63.8pp
- 10-Year Change
- -
Sector benchmark
Top 2% in Health CareTop 2% of 213This company 37.4% Sector average -24.2%
▼
+254.8% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 411.3% year-over-year.
- Currently 61.6pp above the Health Care sector average.
- Lowest return on assets (roa) in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.87 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.5%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 37.4% | +411.3% |
| FY2024 | -12.0% | +60.4% |
| FY2023 | -30.3% | -63.7% |
| FY2022 | -18.5% | +72.6% |
| FY2021 | -67.7% | -156.0% |
| FY2020 | -26.4% | +75.1% |
| FY2019 | -106.3% | +21.1% |
| FY2018 | -134.6% | -159.5% |
| FY2017 | -51.9% | -146.6% |
| FY2016 | -21.0% | -56.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026